AcelRx Pharmaceuticals, Inc.: Launched DSUVIA (sufentanil sublingual tablet 30 mcg) in the US in 1Q19 for acute pain severe enough to require opioid analgesic (adult patients in certified medically supervised healthcare settings). In 3Q19 reported 130 REMS-certified healthcare facilities & 105 formulary approvals. Also developing Zalviso (Ph 3 completed) in the US as an innovative patient-controlled analgesia system for moderate-to-severe acute pain in medically supervised settings.
Healthcare/Drug Manufacturers
Based in...
US - Pacific
Clinical Stage
Phase III, Registration Stage
Disease Space
Biotechnology, Medical Device, Specialty Pharmaceutical
Public, USA
Market Cap
100MM - 500MM
Therapeutic Modalities
Platform Technology
351 Galveston Drive
Redwood City, CA 94063
United States

Top 10 Holders of AcelRx Pharmaceuticals, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
The Vanguard Group, Inc. 4.68 3,717,311 5.84 Funds 8/31/20
Vanguard Group, Inc. (Subfiler) 4.55 3,618,202 5.68 13F 6/30/20
BlackRock Fund Advisors 3.33 2,642,421 4.15 13F 6/30/20
BlackRock Institutional Trust Co. NA 2.97 2,355,703 3.70 13F 6/30/20
Geode Capital Management LLC 1.58 1,252,107 1.97 13F 6/30/20
State Street Corp. 1.37 1,092,115 1.71 13F 6/30/20
D.E. Shaw & Co., Inc. 1.30 1,031,840 1.62 13F 6/30/20
Northern Trust Corp. 1.20 955,582 1.50 13F 6/30/20
Morgan Stanley Capital Services LLC 0.71 566,155 0.89 13F 6/30/20
Bridgeway Capital Management, Inc. 0.44 346,150 0.54 13F 6/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.